Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures

NCT00160550 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Convulsive Epilepsy

Interventions

DRUG: Levetiracetam

Sponsor

UCB Pharma